216 related articles for article (PubMed ID: 32530860)
21. Identification of multidrug-resistant
Yuan Q; Li Y; Xiu L; Zhang C; Fu Y; Jiang C; Tang L; Peng J
Emerg Microbes Infect; 2019; 8(1):1546-1549. PubMed ID: 31661379
[TBL] [Abstract][Full Text] [Related]
22. Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.
Brunner A; Nemes-Nikodem E; Jeney C; Szabo D; Marschalko M; Karpati S; Ostorhazi E
Ann Clin Microbiol Antimicrob; 2016 Sep; 15(1):53. PubMed ID: 27646968
[TBL] [Abstract][Full Text] [Related]
23. Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
Cole MJ; Spiteri G; Chisholm SA; Hoffmann S; Ison CA; Unemo M; Van de Laar M
Euro Surveill; 2014 Nov; 19(45):20955. PubMed ID: 25411689
[TBL] [Abstract][Full Text] [Related]
24. Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.
Młynarczyk-Bonikowska B; Majewska A; Malejczyk M; Młynarczyk G; Majewski S
Med Microbiol Immunol; 2020 Apr; 209(2):95-108. PubMed ID: 31802195
[TBL] [Abstract][Full Text] [Related]
25. Multidrug-resistant
Golparian D; Rose L; Lynam A; Mohamed A; Bercot B; Ohnishi M; Crowley B; Unemo M
Euro Surveill; 2018 Nov; 23(47):. PubMed ID: 30482267
[TBL] [Abstract][Full Text] [Related]
26. Cefixime and ceftriaxone susceptibility of Neisseria gonorrhoeae in Italy from 2006 to 2010.
Carannante A; Prignano G; Cusini M; Matteelli A; Dal Conte I; Ghisetti V; D'Antuono A; Cavrini F; Antonetti R; Stefanelli P
Clin Microbiol Infect; 2012 Jun; 18(6):558-64. PubMed ID: 21966997
[TBL] [Abstract][Full Text] [Related]
27. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales.
Chisholm SA; Alexander S; Desouza-Thomas L; Maclure-Webster E; Anderson J; Nichols T; Lowndes CM; Ison CA;
J Antimicrob Chemother; 2011 Nov; 66(11):2509-12. PubMed ID: 21846672
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial susceptibility profile of
Affolabi D; Goma E; Sogbo F; Ahotin G; Orekan J; Massou F; Behanzin L; Guédou F; Alary M
Sex Transm Infect; 2018 Feb; 94(1):20. PubMed ID: 29021407
[No Abstract] [Full Text] [Related]
29. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae.
Zhao S; Duncan M; Tomberg J; Davies C; Unemo M; Nicholas RA
Antimicrob Agents Chemother; 2009 Sep; 53(9):3744-51. PubMed ID: 19528266
[TBL] [Abstract][Full Text] [Related]
30. Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
Singh AE; Gratrix J; Read R; Lovgren M; Drews SJ; Romanowski B; Sutherland K; Talbot J; Martin I
Sex Transm Dis; 2013 Sep; 40(9):744-50. PubMed ID: 23945428
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.
Lewis DA; Sriruttan C; Müller EE; Golparian D; Gumede L; Fick D; de Wet J; Maseko V; Coetzee J; Unemo M
J Antimicrob Chemother; 2013 Jun; 68(6):1267-70. PubMed ID: 23416957
[TBL] [Abstract][Full Text] [Related]
32. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
[TBL] [Abstract][Full Text] [Related]
33. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.
Ison CA; Town K; Obi C; Chisholm S; Hughes G; Livermore DM; Lowndes CM;
Lancet Infect Dis; 2013 Sep; 13(9):762-8. PubMed ID: 23764300
[TBL] [Abstract][Full Text] [Related]
34. Resistance-Guided Therapy for Neisseria gonorrhoeae.
Allan-Blitz LT; Adamson PC; Klausner JD
Clin Infect Dis; 2022 Oct; 75(9):1655-1660. PubMed ID: 35818315
[TBL] [Abstract][Full Text] [Related]
35. Equations To Predict Antimicrobial MICs in Neisseria gonorrhoeae Using Molecular Antimicrobial Resistance Determinants.
Demczuk W; Martin I; Sawatzky P; Allen V; Lefebvre B; Hoang L; Naidu P; Minion J; VanCaeseele P; Haldane D; Eyre DW; Mulvey MR
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871081
[TBL] [Abstract][Full Text] [Related]
36. Molecular epidemiological typing of
Banhart S; Jansen K; Buder S; Tamminga T; Calvignac-Spencer S; Pilz T; Martini A; Dudareva S; Nikisins S; Dehmel K; Zuelsdorf G; Guhl E; Graeber I; Kohl PK; Unemo M; Bremer V; Heuer D;
Euro Surveill; 2020 Oct; 25(41):. PubMed ID: 33063655
[TBL] [Abstract][Full Text] [Related]
37. Multidrug-resistant
Poncin T; Fouere S; Braille A; Camelena F; Agsous M; Bebear C; Kumanski S; Lot F; Mercier-Delarue S; Ngangro NN; Salmona M; Schnepf N; Timsit J; Unemo M; Bercot B
Euro Surveill; 2018 May; 23(21):. PubMed ID: 29845928
[TBL] [Abstract][Full Text] [Related]
38. Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011.
Kidd S; Lee MV; Maningas E; Komeya A; Kunimoto G; O'Connor N; Katz AR; Wasserman GM; Kirkcaldy RD; Whelen AC
Sex Transm Dis; 2013 Sep; 40(9):756-9. PubMed ID: 23949591
[TBL] [Abstract][Full Text] [Related]
39. Ceftriaxone-Resistant Neisseria gonorrhoeae, Canada, 2017.
Lefebvre B; Martin I; Demczuk W; Deshaies L; Michaud S; Labbé AC; Beaudoin MC; Longtin J
Emerg Infect Dis; 2018 Feb; 24(2):381-3. PubMed ID: 29131780
[TBL] [Abstract][Full Text] [Related]
40. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.
Cámara J; Serra J; Ayats J; Bastida T; Carnicer-Pont D; Andreu A; Ardanuy C
J Antimicrob Chemother; 2012 Aug; 67(8):1858-60. PubMed ID: 22566592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
